UPLOAD Filing
MANGOCEUTICALS, INC.
Date: June 6, 2025 · CIK: 0001938046 · Accession: 0000000000-25-005997
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287689
Letter
Re: Mangoceuticals, Inc. Registration Statement on Form S-1 Filed May 30, 2025 File No. 333-287689 Dear Jacob D. Cohen:
June 6, 2025
Jacob D. Cohen Chief Executive Officer Mangoceuticals, Inc. 15110 N. Dallas Parkway, Suite 600 Dallas, Texas 75248
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Katherine Bagley at 202-551-2545 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Steven Lipstein
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 6, 2025 Jacob D. Cohen Chief Executive Officer Mangoceuticals, Inc. 15110 N. Dallas Parkway, Suite 600 Dallas, Texas 75248 Re: Mangoceuticals, Inc. Registration Statement on Form S-1 Filed May 30, 2025 File No. 333-287689 Dear Jacob D. Cohen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Katherine Bagley at 202-551-2545 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Steven Lipstein </TEXT> </DOCUMENT>